Phase
Condition
N/ATreatment
Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Clinical Study ID
Ages 45-84 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Arm A:
Must be 45-84 years of age.
Must have a suspected advanced adenoma or be newly diagnosed with CRC, still notresected, and scheduled for surgery.
Able to comprehend, sign, and date the written informed consent document.
Arm B:
Must be 45-84 years of age.
Able and willing to undergo a standard-of-care screening colonoscopy within 60 days.
Able to comprehend, sign, and date the written informed consent document.
Exclusion
Exclusion Criteria:
Arm A Only:
- Subject with curative biopsy during colonoscopy.
Arm B Only:
Subjects with positive FIT Test results in the 6 months preceding enrollment.
Subject has a current diagnosis of cancer.
Arms A & B:
Subject has a personal history of aerodigestive or digestive tract cancers.
Subjects having undergone previous partial surgical removal of one or more portionsof their colon due to a reason other than colorectal cancer.
Has a known diagnosis or personal history of any of the following high-riskindications for colorectal cancer:
Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) andCrohn's disease.
Familial adenomatous polyposis ("FAP", including attenuated FAP).
Hereditary non-polyposis colorectal cancer syndrome ("HNPCC" or "LynchSyndrome").
Serrated polyposis syndrome
2 first-degree relatives (e.g., parents, siblings, and offspring) who have beendiagnosed with colon cancer.
One first-degree relative with CRC diagnosed before the age of 60.
A significant disease which, in the Investigator's opinion, would exclude thesubject from the study.
Legal incapacity or limited mental capacity.
Medical or psychological conditions that would not permit the subject to completethe study or sign informed consent.
The patient has a known or documented previous or current medical history ofinfectious diseases that can be transmitted through blood (E.g. Hepatitis, HIV,etc.), including patients that have been treated, are currently being treated, orhave not been treated for that conditions.
The patient is known to be pregnant when recruited or during her participation inthe study.
Study Design
Study Description
Connect with a study center
Precision Recearch Institute
Chula Vista, California 91910
United StatesSite Not Available
Medical Associates Research Group
San Diego, California 92123
United StatesCompleted
Precision Research Institute
San Diego, California 92114
United StatesSite Not Available
Clinical Research of California
Walnut Creek, California 94598
United StatesSite Not Available
Precision Recearch Institute
Chula Vista 5336899, California 5332921 91910
United StatesCompleted
Medical Associates Research Group
San Diego 5391811, California 5332921 92123
United StatesCompleted
Precision Research Institute
San Diego 5391811, California 5332921 92114
United StatesCompleted
Clinical Research of California
Walnut Creek 5406990, California 5332921 94598
United StatesCompleted
Center for Gastrointestinal Disorders
Hollywood, Florida 33021
United StatesSite Not Available
Lakeland Regional Cancer Center
Lakeland, Florida 33805
United StatesSite Not Available
Center for Gastrointestinal Disorders
Hollywood 4158928, Florida 4155751 33021
United StatesCompleted
Lakeland Regional Cancer Center
Lakeland 4161438, Florida 4155751 33805
United StatesActive - Recruiting
Springfield Clinic
Springfield, Illinois 62702
United StatesSite Not Available
Springfield Clinic
Springfield 4250542, Illinois 4896861 62702
United StatesActive - Recruiting
Ochsner Clinic
New Orleans, Louisiana 70121
United StatesSite Not Available
Ochsner Clinic
New Orleans 4335045, Louisiana 4331987 70121
United StatesCompleted
Dana Farber Cancer Institute
Boston, Massachusetts 02215
United StatesSite Not Available
Dana Farber Cancer Institute
Boston 4930956, Massachusetts 6254926 02215
United StatesCompleted
Mid Hudson Medical Research
New Windsor, New York 12553
United StatesSite Not Available
Mid Hudson Medical Research
New Windsor 5128577, New York 5128638 12553
United StatesActive - Recruiting
Fox Chase Cancer Center
Philadelphia, Pennsylvania 19111
United StatesCompleted
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesSite Not Available
Frontier Clinical Research
Uniontown, Pennsylvania 15401
United StatesSite Not Available
Fox Chase Cancer Center
Philadelphia 4560349, Pennsylvania 6254927 19111
United StatesCompleted
University of Pennsylvania
Philadelphia 4560349, Pennsylvania 6254927 19104
United StatesActive - Recruiting
Frontier Clinical Research
Uniontown 4561859, Pennsylvania 6254927 15401
United StatesCompleted
Clinical Trials Network
Union City, Tennessee 38261
United StatesSite Not Available
Clinical Trials Network
Union City 4664170, Tennessee 4662168 38261
United StatesCompleted
Vilo Research Group
Houston, Texas 77017
United StatesSite Not Available
Vilo Research Group
Houston 4699066, Texas 4736286 77017
United StatesCompleted
Gastroenterology Consultants of SW Virginia
Roanoke, Virginia 24014
United StatesSite Not Available
Gastroenterology Consultants of SW Virginia
Raonoke, Virginia 6254928 24014
United StatesCompleted

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.